CSI Market
Sign In | Register

Gb Sciences Inc (GBLX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access GBLX Annual Cash Flow →
Cash flow data covering Gb Sciences Inc–Dec 31 2023 offers a view into how Dec 31 2024's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
9 Months 		(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Operating Activities
Income-0.58
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Intangible Assets, Finite-lived0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Gain Loss On Sale Of Oil And Gas Property-
Induced Conversion Of Convertible Debt Expense-
Gain Loss On Change In Fair Value Of Convetible Notes-
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease-
Allowance For Loan And Lease Losses Period Increase Decrease-
Gain Loss On Sale Of Notes Receivable-
Gain Loss Change In Fair Value Of Convertible Notes-
Increase Decrease Stock Subscription Receivable-
Change In Fair Value Of Convertible Notes-
Increase Decrease In Stock Subscription Receivable-
Interest Expense Debt-
Interest Expense Debt Excluding Amortization-
Stock Issued To Settle Royalty Agreement Value-
Depreciation Capitalized In Inventory-
Induced Dividend From Exercise Of Warrants-
Issuance Of Stock For Services-
Issuance Of Warrants To Brokers-
Gain Loss On Modification Of Notes Receivable-
Deconsolidation Gain Or Loss Amount-
Gain Loss On Collection Of Notes Receivable-
Increase Decrease In Accrued Liabilities Excluding Interest Payable0.15
Income taxes0.00
Gain (Loss) on Investments0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.08
Increase (Decrease) in Interest Payable, Net0.10
Recognition of Deferred Revenue0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-0.25
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Proceeds from Recoveries of Loans Previously Charged off0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Long-term Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.24
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.01
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Increase (Decrease) in Deposits0.00
Other financing activities net0.00
Other net-0.01
Proceeds From Stock Subscription Receivable-
Stock Returned-
Deferred Revenue Additions-
Recognition Of Deferred Revenue From Licensing-
Proceeds From Common Stock-
Payments For Proceeds From Investment In Subsidiary-
Proceeds From Stock Subscription Payable-
Cash And Cash Equivalents Classified As Discontinued Operations-
Cash Paid To Settle Royalty Agreement-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations0.01
Repayments Of Principal Notes Payable And Operating Lease Obligation-
Payments For Brokerage Fees For Exercise Of Warrants-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.25
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.25
Total Cash Flow-0.01
4 historic quarters locked

Sign in to unlock the full Gb Sciences Inc cash flow history.

Sign In Create Free Account

About Gb Sciences Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-25-026237

Figures are derived from filed reports and may be restated. Historical data is subject to revision.